Ontology type: schema:ScholarlyArticle
2011-04
AUTHORSSrikala S. Sridhar, Christina M. Canil, Kim N. Chi, Sebastien J. Hotte, Scott Ernst, Lisa Wang, Eric X. Chen, Agnes Juhasz, Yun Yen, Peter Murray, James A. Zwiebel, Malcolm J. Moore
ABSTRACTPURPOSE: GTI-2040 is a novel antisense oligonucleotide to the R2 subunit of ribonucleotide reductase. This phase II trial was conducted to determine the efficacy and tolerability of GTI-2040 when combined with docetaxel and prednisone for the treatment of patients with castration-resistant prostate cancer (CRPC). METHODS: Chemo-naïve CRPC patients with adequate performance status and organ function were treated with docetaxel 75 mg/m(2) IV on day 1 plus GTI-2040 5 mg/kg/day by continuous intravenous infusion day 1-14 on a 21 day cycle, with prednisone 5 mg orally twice daily. The primary endpoint was PSA response rate. Pharmacokinetic studies of GTI-2040 and pharmacodynamic studies on peripheral blood mononuclear cells (PBMC) were also performed. RESULTS: Twenty-two patients in total (19 from this study and 3 from a prior phase I/II study at this institution) were treated at the recommended phase II dose. A confirmed PSA response was seen in 9/22 patients (41%). Of 16 patients with measurable disease, there was 1 partial response (PR) and 12 stable disease (SD) lasting 3.6 months (median), as best response. The most common toxicities were anemia, fatigue, lymphopenia, leucopenia and neutropenia. Grade 3+ toxicities included neutropenia, lymphopenia, leucopenia, fatigue, febrile neutropenia and hypophosphatemia. CONCLUSIONS: The PSA response rate of GTI-2040 in combination with docetaxel and prednisone just met the minimum phase II criteria for further enrollment. However, after evaluation of all the clinical data, further study of this dose and schedule of GTI-2040 in CRPC was not recommended. More... »
PAGES927-933
http://scigraph.springernature.com/pub.10.1007/s00280-010-1389-7
DOIhttp://dx.doi.org/10.1007/s00280-010-1389-7
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1028116130
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/20602233
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Combined Chemotherapy Protocols",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Follow-Up Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Leukocytes, Mononuclear",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Oligodeoxyribonucleotides",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Orchiectomy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prednisone",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prostate-Specific Antigen",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prostatic Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Taxoids",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"name": [
"Princess Margaret Hospital, Phase II Consortium, University of Toronto, 610 University Avenue, Suite 5-222, M5G 2M9, Toronto, ON, USA"
],
"type": "Organization"
},
"familyName": "Sridhar",
"givenName": "Srikala S.",
"id": "sg:person.01204166657.51",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204166657.51"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Ottawa Regional Cancer Centre, Ottawa, ON, USA"
],
"type": "Organization"
},
"familyName": "Canil",
"givenName": "Christina M.",
"id": "sg:person.0617500177.29",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617500177.29"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"BC Cancer Agency, Vancouver, BC, USA"
],
"type": "Organization"
},
"familyName": "Chi",
"givenName": "Kim N.",
"id": "sg:person.01142252161.65",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142252161.65"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Juravinski Cancer Center, Hamilton, ON, USA"
],
"type": "Organization"
},
"familyName": "Hotte",
"givenName": "Sebastien J.",
"id": "sg:person.01116377030.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116377030.40"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"London Regional Cancer Center, London, ON, USA"
],
"type": "Organization"
},
"familyName": "Ernst",
"givenName": "Scott",
"id": "sg:person.01236307062.83",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236307062.83"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Princess Margaret Hospital, Phase II Consortium, University of Toronto, 610 University Avenue, Suite 5-222, M5G 2M9, Toronto, ON, USA"
],
"type": "Organization"
},
"familyName": "Wang",
"givenName": "Lisa",
"id": "sg:person.012667465007.49",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012667465007.49"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Princess Margaret Hospital, Phase II Consortium, University of Toronto, 610 University Avenue, Suite 5-222, M5G 2M9, Toronto, ON, USA"
],
"type": "Organization"
},
"familyName": "Chen",
"givenName": "Eric X.",
"id": "sg:person.0754450325.91",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754450325.91"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"City of Hope National Medical Centre, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Juhasz",
"givenName": "Agnes",
"id": "sg:person.01007474330.73",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007474330.73"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"City of Hope National Medical Centre, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Yen",
"givenName": "Yun",
"id": "sg:person.0760103773.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760103773.19"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Lorus Therapeutics Inc, Toronto, ON, USA"
],
"type": "Organization"
},
"familyName": "Murray",
"givenName": "Peter",
"type": "Person"
},
{
"affiliation": {
"alternateName": "National Cancer Institute",
"id": "https://www.grid.ac/institutes/grid.48336.3a",
"name": [
"Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA"
],
"type": "Organization"
},
"familyName": "Zwiebel",
"givenName": "James A.",
"id": "sg:person.01123742514.34",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123742514.34"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Princess Margaret Hospital, Phase II Consortium, University of Toronto, 610 University Avenue, Suite 5-222, M5G 2M9, Toronto, ON, USA"
],
"type": "Organization"
},
"familyName": "Moore",
"givenName": "Malcolm J.",
"id": "sg:person.07455026572.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07455026572.07"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1158/1078-0432.ccr-07-0944",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006922944"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00280-009-1163-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011933531",
"https://doi.org/10.1007/s00280-009-1163-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00280-009-1163-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011933531",
"https://doi.org/10.1007/s00280-009-1163-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00280-009-1163-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011933531",
"https://doi.org/10.1007/s00280-009-1163-x"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.jchromb.2005.09.036",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015047150"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa041318",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028543233"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa040720",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029249997"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-08-0109",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031820808"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/jnci/92.3.205",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032301848"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdi178",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050255200"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/0197-2456(89)90015-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1053744925"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/0197-2456(89)90015-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1053744925"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1021/bi00475a007",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1055177617"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1023/a:1008332724977",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1056303222"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3892/or.15.5.1299",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1071530002"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1999.17.11.3461",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1074545753"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1075013035",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1075295406",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1077265246",
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2005.23.16_suppl.7253",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1079368204"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1083167129",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1083251660",
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2010.28.18_suppl.lba4511",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1083946811"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1115/icem2007-7291",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1092859094"
],
"type": "CreativeWork"
}
],
"datePublished": "2011-04",
"datePublishedReg": "2011-04-01",
"description": "PURPOSE: GTI-2040 is a novel antisense oligonucleotide to the R2 subunit of ribonucleotide reductase. This phase II trial was conducted to determine the efficacy and tolerability of GTI-2040 when combined with docetaxel and prednisone for the treatment of patients with castration-resistant prostate cancer (CRPC).\nMETHODS: Chemo-na\u00efve CRPC patients with adequate performance status and organ function were treated with docetaxel 75 mg/m(2) IV on day 1 plus GTI-2040 5 mg/kg/day by continuous intravenous infusion day 1-14 on a 21 day cycle, with prednisone 5 mg orally twice daily. The primary endpoint was PSA response rate. Pharmacokinetic studies of GTI-2040 and pharmacodynamic studies on peripheral blood mononuclear cells (PBMC) were also performed.\nRESULTS: Twenty-two patients in total (19 from this study and 3 from a prior phase I/II study at this institution) were treated at the recommended phase II dose. A confirmed PSA response was seen in 9/22 patients (41%). Of 16 patients with measurable disease, there was 1 partial response (PR) and 12 stable disease (SD) lasting 3.6 months (median), as best response. The most common toxicities were anemia, fatigue, lymphopenia, leucopenia and neutropenia. Grade 3+ toxicities included neutropenia, lymphopenia, leucopenia, fatigue, febrile neutropenia and hypophosphatemia.\nCONCLUSIONS: The PSA response rate of GTI-2040 in combination with docetaxel and prednisone just met the minimum phase II criteria for further enrollment. However, after evaluation of all the clinical data, further study of this dose and schedule of GTI-2040 in CRPC was not recommended.",
"genre": "research_article",
"id": "sg:pub.10.1007/s00280-010-1389-7",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isFundedItemOf": [
{
"id": "sg:grant.2426791",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1088364",
"issn": [
"0344-5704",
"1432-0843"
],
"name": "Cancer Chemotherapy and Pharmacology",
"type": "Periodical"
},
{
"issueNumber": "4",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "67"
}
],
"name": "A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer",
"pagination": "927-933",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"85f03debb1265c2f8da6fcd723e1099d1b7df7557bce34ae0cbd597612af2b90"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"20602233"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"7806519"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00280-010-1389-7"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1028116130"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00280-010-1389-7",
"https://app.dimensions.ai/details/publication/pub.1028116130"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T17:32",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000513.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007%2Fs00280-010-1389-7"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1389-7'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1389-7'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1389-7'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-010-1389-7'
This table displays all metadata directly associated to this object as RDF triples.
283 TRIPLES
21 PREDICATES
64 URIs
35 LITERALS
23 BLANK NODES